BRIEF-GenSight Biologics gets orphan drug designation for GS030

* Obtains orphan drug designation in the US for GS030 in pigmentary retinopathy [Source]

Publication Date: Tuesday, 31 January 2017 at 08:44:36

Origin: reuters.com

Category: rbssHealthcareNews

Topics: GS030, designation, orphan, retinopathy, in pigmentary, Obtains, Biologics, BRIEF-GenSight

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/eesJT-ZbaJ4/idUSFWN1FL024

Related Articles

Drugmakers look for reciprocal UK-EU regulation after Brexit

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:26:46

UPDATE 1-Opioid addiction implant maker Braeburn Pharma pulls IPO

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:10:46

BRIEF-Nestle Health Science plans to expand manufacturing facility in Eau Claire, Wi

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 17:45:15

BRIEF-Medivir says EGM backs redemption programme

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:54:21

BRIEF-Cymabay announces pricing of public offering of common stock

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:37:22